Works by Lamb, Lawrence

Results: 23

Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.

Published in:

2016

By:

Bauer, David F.;
Pereboeva, Larisa;
Gillespie, G. Yancey;
Cloud, Gretchen A.;
Elzafarany, Osama;
Langford, Catherine;
Markert, James M.;
Jr., Lawrence S. Lamb;
Lamb, Lawrence S Jr

Publication type:

journal article

The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 551, doi. 10.1007/s00262-015-1662-z

By:

Pereboeva, Larisa;
Harkins, Lualhati;
Wong, Shun;
Lamb, Lawrence

Publication type:

Article

Characterization of the γδ T cell response to acute leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1072, doi. 10.1007/s00262-005-0094-6

By:

Meeh, Paul F.;
King, Michelle;
O'Brien, Rebecca L.;
Muga, Stephanie;
Buckhalts, Philip;
Neuberg, Ronnie;
Lamb Jr, Lawrence S.

Publication type:

Article

A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00536-8

By:

Lamb, Lawrence S.;
Pereboeva, Larisa;
Youngblood, Samantha;
Gillespie, G. Yancey;
Nabors, L. Burton;
Markert, James M.;
Dasgupta, Anindya;
Langford, Catherine;
Spencer, H. Trent

Publication type:

Article

Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma.

Published in:

PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0122387

By:

Beck, Benjamin H.;
Kim, Hyunggoon;
O’Brien, Rebecca;
Jadus, Martin R.;
Gillespie, G. Yancey;
Cloud, Gretchen A.;
Hoa, Neil T.;
Langford, Catherine P.;
Lopez, Richard D.;
Harkins, Lualhati E.;
Lamb Jr., Lawrence S.

Publication type:

Article

Broad T-Cell Receptor Repertoire in T-Lymphocytes Derived from Human Induced Pluripotent Stem Cells.

Published in:

PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097335

By:

Chang, Chia-Wei;
Lai, Yi-Shin;
Lamb Jr., Lawrence S.;
Townes, Tim M.

Publication type:

Article

DNA Damage Responses and Oxidative Stress in Dyskeratosis Congenita.

Published in:

PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0076473

By:

Pereboeva, Larisa;
Westin, Erik;
Patel, Toral;
Flaniken, Ian;
Lamb, Lawrence;
Klingelhutz, Aloysius;
Goldman, Frederick

Publication type:

Article

CMV-Independent Lysis of Glioblastoma by <i>Ex Vivo</i> Expanded/Activated Vδ1+ γδ T Cells.

Published in:

PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0068729

By:

Knight, Andrea;
Arnouk, Hilal;
Britt, William;
Gillespie, G. Yancey;
Cloud, Gretchen A.;
Harkins, Lualhati;
Su, Yun;
Lowdell, Mark W.;
Lamb, Lawrence S.

Publication type:

Article

Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy.

Published in:

PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0051805

By:

Lamb Jr., Lawrence S.;
Bowersock, Joscelyn;
Dasgupta, Anindya;
Gillespie, G. Yancey;
Su, Yun;
Johnson, Austin;
Spencer, H. Trent

Publication type:

Article

Increments of Transformation From Midnight to Daylight.

Published in:

Journal of Transformative Education, 2015, v. 13, n. 4, p. 341, doi. 10.1177/1541344615587112

By:

Arroyo, Andrew T.;
Kidd, Angel R.;
Burns, Susan M.;
Cruz, Ivan J.;
Lawrence-Lamb, Judy E.

Publication type:

Article

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.

Published in:

2017

By:

Minagawa, Kentaro;
Jamil, Muhammad O.;
AL-Obaidi, Mustafa;
Pereboeva, Larisa;
Salzman, Donna;
Erba, Harry P.;
Lamb, Lawrence S.;
Bhatia, Ravi;
Mineishi, Shin;
Di Stasi, Antonio

Publication type:

Correction Notice

In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.

Published in:

PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0166891

By:

Minagawa, Kentaro;
Jamil, Muhammad O.;
AL-Obaidi, Mustafa;
Pereboeva, Larisa;
Salzman, Donna;
Erba, Harry P.;
Lamb, Lawrence S.;
Bhatia, Ravi;
Mineishi, Shin;
Di Stasi, Antonio

Publication type:

Article

Cryopreserved normal macrophages as a control for assays of macrophage function.

Published in:

1999

By:

Lamb, Lawrence;
Willoughby, William;
Willoughby, Judith

Publication type:

Letter

γδ T cells as immune effectors against high-grade gliomas.

Published in:

Immunologic Research, 2009, v. 45, n. 1, p. 85, doi. 10.1007/s12026-009-8114-9

By:

Lamb, Lawrence

Publication type:

Article

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.

Published in:

Journal of Neuro-Oncology, 2011, v. 101, n. 2, p. 179, doi. 10.1007/s11060-010-0245-2

By:

Bryant, Nichole;
Gillespie, G.;
Lopez, Richard;
Markert, James;
Cloud, Gretchen;
Langford, Catherine;
Arnouk, Hilal;
Su, Yun;
Haines, Hilary;
Suarez-Cuervo, Catalina;
Lamb, Lawrence

Publication type:

Article

Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Published in:

Journal of Clinical Laboratory Analysis, 2005, v. 19, n. 2, p. 47, doi. 10.1002/jcla.20055

By:

Roger S. Riley;
Michael Idowu;
Alden Chesney;
Shawn Zhao;
John McCarty;
Lawrence S. Lamb;
Jonathan M. Ben‐Ezra

Publication type:

Article

Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma.

Published in:

Cancers, 2024, v. 16, n. 16, p. 2852, doi. 10.3390/cancers16162852

By:

Jones, Amber B.;
Tuy, Kaysaw;
Hawkins, Cyntanna C.;
Quinn, Colin H.;
Saad, Joelle;
Gary, Sam E.;
Beierle, Elizabeth A.;
Ding, Lei;
Rochlin, Kate M.;
Lamb, Lawrence S.;
Hjelmeland, Anita B.

Publication type:

Article

Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.

Published in:

Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092339

By:

Jones, Amber B.;
Rocco, Abbey;
Lamb, Lawrence S.;
Friedman, Gregory K.;
Hjelmeland, Anita B.

Publication type:

Article

Cytotoxic and Regulatory Properties of Circulating Vδ1+ γδ T Cells: A New Player on the Cell Therapy Field?

Published in:

Molecular Therapy, 2014, v. 22, n. 8, p. 1416, doi. 10.1038/mt.2014.104

By:

Siegers, Gabrielle M;
Lamb, Lawrence S

Publication type:

Article

Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias.

Published in:

British Journal of Haematology, 2001, v. 114, n. 1, p. 11, doi. 10.1046/j.1365-2141.2001.02906.x

By:

Lowdell, Mark W.;
Lamb, Lawrence;
Hoyle, Christine;
Velardi, Andrea;
Prentice, H. Grant

Publication type:

Article

Phase II clinical trial of one dose of post‐transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched‐unrelated donor transplantation.

Published in:

American Journal of Hematology, 2021, v. 96, n. 10, p. E396, doi. 10.1002/ajh.26296

By:

Jamy, Omer;
Innis‐Shelton, Raquel;
Bal, Susan;
Paluri, Ravi;
Salzman, Donna;
Di Stasi, Antonio;
Costa, Luciano;
Meredith, Ruby;
Lamb, Lawrence;
Minagawa, Kentaro;
Mineishi, Shin;
Saad, Ayman

Publication type:

Article

IMMU-15. ENGINEERED-DRUG RESISTANT GAMMA-DELTA (γδ) T CELLS COMBINED WITH IMMUNE CHECKPOINT BLOCKADE AUGMENTED KILLING OF CANCER CELLS.

Published in:

Neuro-Oncology, 2018, v. 20, p. vi124, doi. 10.1093/neuonc/noy148.518

By:

Pillai, Sailesh Gopalakrishna;
Gillespie, Yancey;
Langford, Cathy;
Langford, Samantha;
Spencer, Trent;
Lamb, Lawrence S

Publication type:

Article

Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1626, doi. 10.3109/10428194.2014.974041

By:

Innis-Shelton, Racquel D.;
Davis, Randall S.;
Lamb, Lawrence;
Mineishi, Shin

Publication type:

Article